Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fulminant hepatic failure associated with methyldopa

A R Puppala, F U Steinheber

    The American Journal of Gastroenterology
    |December 1, 1977
    PubMed
    Summary

    Methyldopa can cause severe liver damage, including fatal submassive hepatic necrosis. This case highlights a rare but serious adverse reaction to the drug, emphasizing the need for vigilance in patients undergoing treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Colopleural fistula presenting as tension pneumothorax in strangulated diaphragmatic hernia. Report of a case.

    Diseases of the colon and rectum·1989
    Same author

    Amebic liver abscess without obvious risk factors.

    New York state journal of medicine·1987
    Same author

    Association of diabetes mellitus with gastric bezoar formation.

    Archives of internal medicine·1987
    Same author

    Rightward shift of colon cancer. A feature of the aging gut.

    Journal of clinical gastroenterology·1986
    Same author

    Ageing and the stomach.

    Clinics in gastroenterology·1985
    Same author

    Small bowel obstruction due to disease of epiploic appendage.

    The American journal of gastroenterology·1981

    Area of Science:

    • Hepatology
    • Clinical Toxicology
    • Immunology

    Background:

    • Methyldopa is a medication commonly used to treat hypertension.
    • Drug-induced liver injury (DILI) is a significant concern in pharmacotherapy.
    • Hepatic necrosis represents severe liver cell death.

    Observation:

    • A patient developed fatal submassive hepatic necrosis following methyldopa administration.
    • The patient presented with a positive L.E. cell preparation, suggesting an autoimmune component.
    • Review of literature identified two prior cases of methyldopa-induced submassive hepatic necrosis.

    Findings:

    • Methyldopa is an occasional cause of severe hepatitis.
    • The drug can manifest as chronic active hepatitis.
    • Submassive hepatic necrosis is a rare but documented adverse effect of methyldopa.

    Implications:

    • This case underscores the potential for severe hepatotoxicity with methyldopa.
    • Positive L.E. cell preparation may indicate a specific susceptibility or mechanism in DILI.
    • Clinicians should be aware of rare but life-threatening liver reactions to methyldopa.

    Related Experiment Videos